METHOD DEVELOPMENT AND STABILITY STUDY BY CHRO-MATOGRAPHIC METHOD FOR PERAMPANEL IN API AND TABLET DOSAGE FORM

Authors

  • Dr. Chirag. J. Patel Professor, Department of Pharmaceutical Analysis, Shree Swaminarayan Sanskar Pharmacy College, Gandhinagar, Gujarat, India.
  • Sonu S. Patel Department of Pharmaceutical Analysis, Gujarat Technological University, Ahmedabad, Gujarat, India,
  • Dr. M. M. Patel Principal, Shree Swaminarayan Sanskar Pharmacy College, Gandhinagar, Gujarat, India.

Keywords:

HPLC, Perampanel, API, Tablet dosage form, OPA, TEA

Abstract

To develop precise , accurate and reproducible stability assay method by RP-HPLC for estimation of Perampanel in API and Tablet dosage form.The adequate separation was carried using whatman ODS partisil column (250mm*4.6mm* 5?m)  using ACN:Buffer (0.5 ml Triethylamine in 500 ml water adjust pH 2.5 with OPA)  (60:40v/v).Detecting wavelength is 227 nm and Rt- 2.960 for API and 3.007 min for Tablet respectively.Linearity for Perampanel was found in the range of 50 -150 µg/ml (R2 = 0.99) respectively. The Accuracy of the present method was evaluated at 50 %,100% and 150%. The % recoveries of Perampanel API and Tablet were found to be in the range of 95.57 – 98.51 % and 94.57 – 97.57 % respectively. Precision studies were carried out and the RSD values were less than two. The method was found to be robust.The proposed method was found to be specific, accurate, precise and robust can be used for estimation of Perampanel in API and Tablet dosage form.

Downloads

Download data is not yet available.

References

“Drug Profile” https : // www. Fycompa. Com/hcp/Mechnism-of-action-pgtc

Sethi PD, HPLC Quantitative Analysis Of Pharmaceutical Formulations, 3rdEdn, CBS Publication and Distributors New Delhi, 2001, pp 1-20, 99-105.

U.S. EPA, “Guidance for Method development and Method Validation for the Resource Conservation and Recovery Act (RCRA) Program”, 1995, www.epa.gov/sw-846/pdfs/methdev.pdf

Hamilton RJ, Sevell PA, Introduction to HPLC, 2ndEdn, Chapman and Hall London Publication, 1982, pp 189.

Beckett A.H, and Stenlake J. B, Practical Pharmaceutical Chemistry, 1stEdn, CBS Publishers and Distributors New Delhi, 2004, pp 275-325.

Dr. S. Ravi Shankar, Textbook of Pharmaceutical Analysis, 3rdEdn, RX Publication, 2014, pp 13.1, 13.3, 18.2 and 18.5.

Vogel’s, Textbook of Quantitative Chemical Analysis, 5th Edn, Pearson Education Limited Publication, 1996, pp 645-651, 752-755.

Sharma S, Sher P, Badve S, Atmaram P.P, Recent Advances in Spectroscopic techniques, 6th Edn, AAPS Pharm Science Technology Publication, 2005, pp 618-625.

ICH Harmonized tripartitle guideline, Validation of Analytical Procedures: Text and Methodology, Q2 (R1), 2005, pp 8-17.

Ahuja s, and Dong MW, Handbook of Pharmaceutical Analysis by HPLC, 1stEdn, Elsevier Academic Press, United Kingdom, 2005, pp 62-68.

Singh SS and Bakshi M, “Development of validated stability indicating assay methods: critical review”, Journal of Pharmaceutical and biomedical analysis, April 2002,pp11–40.

SchirmerRE, Modern MethodsofPharmaceutical Analysis, CRCPressInc, 1982,pp61-138.

Cartenson JT, and Swarbirck J, Solution kinetics- Drug stability principles and practice, 2nd Edn, Marcel Dekker series, 1995, pp 17-90.

Stability Testing of New Drugs and Product: ICH Q1 A (R2). 2003, pp 1-20.

Charde MS, Kumar J, Welankiwar AS and Chakole RD, “Review: development of forced degradation studies of drugs”, International Journal of Advances in Pharmaceutics,December 2013, pp34-38.

Hotha KK, Reddi SK, Raju VK andRavindranath LK, “Forced degradation studies: practical approach- overview of regulatory guidance and literature for the drug substances and drug products”,International Research Journal of Pharmacy, July2013, pp78-83.

Ngwa G, “Forced degradation study as an integral part of HPLC stability-indicating

Validation of Analytical Procedure: Text and Methodology ICH, Q2 (R1).2005, pp 1-13.

“Drug profile” September 2016,www. Drugbank.Ca/drugs/DB08883

Yuji Mano, Osamu Takenaka and KazutomiKusano, “High-perfomance liquid chromatography-tandem mass spectrometry method for the determination of perampanela novel ?-amino-3-hydrxy-5-methyl-4-isoxazolepropionic acid receptor antagonist in human plasma”. J.of.Pharmaceutical.and Biomedical Analysi. 2015, 107,56-62

Yuji Mano, Osamu Takenaka and KazutomiKusano, “HPLC with fluorescence detection assay of perampanel,a novel AMPA receptor antagonist, in human plasma for clinical pharmacokinetic studies”. J.of.Biomedchromatogr. 2015,29, 1589-1593

Yuji Mano, “An inter- laboratory cross-validation study for the determination of perampanel in human plasma by liquid chromatography assays”. J. Of Biomed chromatogr. 2016, 1-3.

Published

2017-07-06
Statistics
185 Views | 478 Downloads
Citatons

How to Cite

Dr. Chirag. J. Patel, Sonu S. Patel, and Dr. M. M. Patel. “METHOD DEVELOPMENT AND STABILITY STUDY BY CHRO-MATOGRAPHIC METHOD FOR PERAMPANEL IN API AND TABLET DOSAGE FORM”. International Journal of Pharmaceutics and Drug Analysis, vol. 5, no. 7, July 2017, pp. 229-40, https://ijpda.org/index.php/journal/article/view/294.

Issue

Section

Research Articles
Share |